Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 30, 2020BMJOpen Access

Drug treatments for covid-19: living systematic review and network meta-analysis

View Full Paper
Ask AI
Bookmark
Share

Authors

RSReed SiemieniukImpactJBJessica J BartoszkoPublic Health Agency of CanadaDZDena ZeraatkarDalhousie University

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Siemieniuk et al. (2020) studied this question.

synapsesocial.com/papers/69d80fb95c3030ff03d18f37https://doi.org/10.1136/bmj.m2980
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia2020 · 1,330 citations
  2. 2Remdesivir for the Treatment of Covid-19 — Final Report2020 · 7,756 citations
  3. 3A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-192020 · 5,526 citations